Abstract
IL2-PE40 is a chimeric protein composed of human interleukin-2 (IL2) genetically fused to a modified form of Pseudomonas exotoxin lacking the cell recognition domain. IL2-PE40 is cytotoxic for IL2 receptor-bearing lymphocytes in culture and can inhibit activation of T cells in vivo. IL2-PE40 can significantly diminish antigen-stimulated proliferation of lymphocytes sensitized to myelin basic protein. Intraperitoneal administration of IL2-PE40 not only markedly inhibits the clinical manifestations of adoptively transferred relapsing experimental allergic encephalomyelitis but also dramatically reduces both inflammation and demyelination characteristic of the disease.
Original language | English |
---|---|
Pages (from-to) | 209-217 |
Number of pages | 9 |
Journal | Journal of Neuroimmunology |
Volume | 32 |
Issue number | 3 |
DOIs | |
State | Published - Jun 1991 |
Externally published | Yes |
Bibliographical note
Funding Information:This work was supported by VA Merit Review Funds and by Research Grant 1929-A-1 from the Multiple Sclerosis Society. We gratefully acknowledge the technical assistance of Craig Kamerath, Greg Gilson, Beckie McLain and Huschang Komeyli.
Funding Information:
Supported by VA Merit Review and Research Grant 1929-A-1 from the National Multiple Sclerosis Society, U.S.A.
Keywords
- Chimeric cytotoxin
- Experimental allergic encephalomyelitis
- Interleukin-2
- Pseudomonas exotoxin